Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-23-023824

Head of Development sold 431 shares at $269.43 ($116,124)

  • Head of Development gave up 807 shares (to pay taxes)
  • Head of Development acquired 1,668 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Singhal Priya · Head of Development

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-09-01 Exercise or conversion : show line 1 in the form 10b5-1 +1,668 4,592.09 D
2023-09-01 Shares withheld for taxes : show line 2 in the form 10b5-1 −807 $267.17 $215,606 3,785.09 D
2023-09-05 Sale : show line 3 in the form 10b5-1 −431 $269.43 $116,124 3,354.09 D
Open-market sales · 431 sh · avg $269.43 · $116,124

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-01 Exercise or conversion : show line 4 in the form 10b5-1 Restricted Stock Unit −1,668 3,337 D
Loading xslF345X05/form4.xml…